Phase 1 study: New medicine extends terminally-ill cancer patients' lives. Seventy percent of the patients who tested the medicine were stable after six weeks. Twelve continued the medication and were stable for 18 weeks. One woman took the medication for 17 months, and was stable for over two years nature.com Submitted by Wagamaga t3_11yy6x6 on March 22, 2023 at 9:56 PM in science 24 comments 286
Viewing a single comment thread. View all comments